TH130271B - It is used for the treatment of new diseases of 4- [2- (4-methylphenyl sulfanyl) phenyl] piperidine - Google Patents
It is used for the treatment of new diseases of 4- [2- (4-methylphenyl sulfanyl) phenyl] piperidineInfo
- Publication number
- TH130271B TH130271B TH801001317A TH0801001317A TH130271B TH 130271 B TH130271 B TH 130271B TH 801001317 A TH801001317 A TH 801001317A TH 0801001317 A TH0801001317 A TH 0801001317A TH 130271 B TH130271 B TH 130271B
- Authority
- TH
- Thailand
- Prior art keywords
- treatment
- phenyl
- piperidine
- depression
- new diseases
- Prior art date
Links
- CVASBKDYSQKLSO-UHFFFAOYSA-N Tedatioxetine Chemical compound C1=CC(C)=CC=C1SC1=CC=CC=C1C1CCNCC1 CVASBKDYSQKLSO-UHFFFAOYSA-N 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims abstract 3
- 239000011780 sodium chloride Substances 0.000 claims abstract 3
- 239000002253 acid Substances 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 3
- 101700063516 ADFA Proteins 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 206010003736 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 201000006287 attention deficit hyperactivity disease Diseases 0.000 abstract 1
Abstract
ให้การใช้ 4-[2-(4-เมธิลฟีนิลซัลฟานิล)ฟีนิล] ไพเพอริดิน และเกลือของสารเหล่านี้ที่เติมด้วย กรดสำหรับรักษา ADHD, อาการซึมเศร้าแบบมีแลนโคเลีย, การรักษาภาวะซึมเศร้าที่ดื้ยา หรือ อาการที่หลงเหลืออยู่ในถาวะซึมเศร้า The use of 4- [2- (4-methylphenyl sulfanyl) phenyl] piperidin and salts of these substances were added. Acid for ADHD, Melanocolia Depression, Medicinal Depression, or Remnants of Depression
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20090174880 EP2236222B1 (en) | 2008-11-04 | 2009-11-03 | An apparatus for cleaning a vehicle's evaporator coil |
Publications (2)
Publication Number | Publication Date |
---|---|
TH130271B true TH130271B (en) | 2013-12-16 |
TH130271A TH130271A (en) | 2013-12-16 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2014515013A5 (en) | ||
NZ594597A (en) | Substituted piperidines as ccr3 antagonists | |
JP2010265321A5 (en) | ||
IL237820A (en) | Use of 4-(1-carboxy-ethylcarbamoyl)-4-(5-[1,2]dithiolan-3-yl-pentanoylamino)-butyric acid derivatives in the manufacture of medicaments | |
BR112014015363A2 (en) | alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors | |
JP2015512931A5 (en) | ||
AR097204A1 (en) | SOLID TUMORS TREATMENT METHODS | |
PE20140252A1 (en) | ((R) - (E) -2- (4- (2- (5- (1- (3,5-DICHLOROPIDIN-4-IL) ETOXY) -1H-INDAZOL-3-IL) VINYL) -1H- PYRAZOLE-1-IL) CRYSTALLINE ETHANOL AS FGRF INHIBITOR | |
NZ710574A (en) | Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors | |
JP2014521744A5 (en) | ||
BR112013029999A2 (en) | thiazole derivatives | |
UA97660C2 (en) | Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]piperidine | |
EA201792072A2 (en) | GLUTARIMIDES DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS OF THEIR PRODUCTION | |
JP2012180360A5 (en) | ||
RU2016124158A (en) | COMPOSITION FOR CARE FOR THE ORAL EMPLOYMENT CONTAINING SERINE AND AT LEAST ZINC SALT | |
AR074350A1 (en) | CRYSTAL FORM OF A COMPOUND OF 4- (2- (2- FLUOROPHENOXIMETHYL) PHENYL) PIPIRIDINE | |
JP2011046708A5 (en) | ||
JP2015516419A5 (en) | ||
ATE501121T1 (en) | 4-Ä(3- FLUORPHENOXY)PHENYLMETHYLÜPIPERIDINE METHANESULFOATE USES, SYNTHETIC METHODS AND PHARMACEUTICAL COMPOSITIONS | |
BR112014009165A2 (en) | salt and medical use | |
BR112014014869A2 (en) | sulfonylaminopyrrolidinone derivatives, their preparation and their therapeutic application | |
EA201000701A1 (en) | 4- [4- (2-ADAMANTHYLKARBAMOIL) -5-TRET-BUTYL-Pyrazole-1-IL] BENZOIC ACID-465 | |
NO20082369L (en) | New vinyl acid acid derivatives | |
MX2009009388A (en) | Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phen yl]piperidine. | |
TH130271B (en) | It is used for the treatment of new diseases of 4- [2- (4-methylphenyl sulfanyl) phenyl] piperidine |